logo-loader
viewOptiBiotix Health PLC

Optibiotix is a very clever business model says chairman

Optibiotix PLC (LON:OPTI) is a very clever business model says chairman Neil Davidson, who just bought a sizeable chunk of additional shares in the microbiome-based additives business.

Recent licensing agreements will turn into revenue streams later this year and the business will go from strength to strength, he believes.

The key is to get Optibiotix’s technology into everyday products - sweeteners, for example, will be huge he told Proactive.

Quick facts: OptiBiotix Health PLC

Price: 63.5 GBX

AIM:OPTI
Market: AIM
Market Cap: £54.25 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of OptiBiotix Health PLC named herein, including the promotion by the Company of OptiBiotix Health PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investors 'beginning to realise the potential' in OptiBiotix Health - CEO

Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI), discusses with Proactive's Andrew Scott the company's recent share price performance and outlines what he's hoping to achieve over the next 6-12 months. ''There really is a big opportunity in the microbiome space which...

on 17/7/18

2 min read